Bambermycins (flavomycin) is a complex of antibiotics obtained from Streptomyces bambergiensis and Streptomyces ghanaensis used as a food additive for poultry and swine. Inhibitor of the in vitro transglycosylase activities of PBPs. Bambermycins complex consists mainly of moenomycins A and C. Moenomycin A is the prototype for compounds that bind to bacterial peptidoglycan glycosyltransferases (PGTs) and inhibit cell wall biosynthesis
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | GAINPRO Approved UseFor increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter (feedlot cattle). For increased rate of weight gain in pasture cattle (slaughter, stocker and feeder cattle, and dairy and beef replacement heifers). Launch Date1998 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors. | 2013-03-13 |
|
| Complete characterization of the seventeen step moenomycin biosynthetic pathway. | 2009-09-22 |
|
| Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota. | 2009-04 |
|
| Effect of flavophospholipol on conjugation frequency between Escherichia coli donor and recipient pairs in vitro and in the chicken gastrointestinal tract. | 2006-08 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/pro/flavomycin.html
Chickens: 1-2 Grams
Swine: 2 Grams
It is recommended that Flavomycin 4 (Bambermycins) be diluted with a suitable grain carrier before addition to the final feed.
A dilution of 1 part of Flavomycin 4 and 9 parts grain carrier is the suggested working premix.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19545513
Of 10 predominant bacterial genera from the fresh human fecal
samples, Fusobacterium spp. and Lactobacillus spp. were the most
sensitively affected by flavomycin (Bambermycins) showing MIC50 value of
0.25 ug/ml at 1 x10(5) CFU/ml. ATCC-type Fusobacterium prausnitzii
was also the most sensitive bacterium with same MIC value
0.25 ug/ml at 1x 10(5) CFU/ml.
| Substance Class |
Mixture
Created
by
admin
on
Edited
Mon Mar 31 18:40:36 GMT 2025
by
admin
on
Mon Mar 31 18:40:36 GMT 2025
|
| Record UNII |
PP922A42V2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C258
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
||
|
CFR |
21 CFR 558.95
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
||
|
CFR |
21 CFR 558.95
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1367176
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | RxNorm | ||
|
300000029420
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
DTXSID90891348
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
PP922A42V2
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
11015-37-5
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
Bambermycin
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
m2215
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | Merck Index | ||
|
28908
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
PP922A42V2
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
2666
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108902
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
DB11377
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
C90675
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY | |||
|
234-246-7
Created by
admin on Mon Mar 31 18:40:36 GMT 2025 , Edited by admin on Mon Mar 31 18:40:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |